Alok Jaju

1.3k citations
31 papers · 377 indexed · h-index 11
Topics
Glioma Diagnosis and Treatment (12 papers)Neuroblastoma Research and Treatments (7 papers)Sarcoma Diagnosis and Treatment (6 papers)

In The Last Decade

Alok Jaju

29 papers receiving 371 citations

Peers

Alok Jaju
Comparison fields: 5 of 60
  • Genetics 183
  • Surgery 93
  • Neurology 92
  • Radiology, Nuclear Medicine and Imaging 79
  • Molecular Biology 72
Replace Nasuda Danchaivijitr with:
Nasuda Danchaivijitr Thailand
Emilia Pecori Italy
John Fort United States
Sushila Jaiswal India
Michael Karremann Germany
Rina Dvir Israel
Feng-Chi Chang Taiwan
Larry E. Kun United States
Thomas J. Stoffel United States
Steven Halpern United States
Alok Jaju relative to Nasuda Danchaivijitr Thailand Nasuda Danchaivijitr's profile →
Citations per field
00.5×10×20×30×36×
Nasuda Danchaivijitr · 1×
Citations per year

Countries citing papers authored by Alok Jaju

Since Specialization
Citations

This map shows the geographic impact of Alok Jaju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok Jaju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok Jaju more than expected).

Fields of papers citing papers by Alok Jaju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alok Jaju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok Jaju. The network helps show where Alok Jaju may publish in the future.

Co-authorship network of co-authors of Alok Jaju

This figure shows the co-authorship network connecting the top 25 collaborators of Alok Jaju. A scholar is included among the top collaborators of Alok Jaju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alok Jaju. Alok Jaju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 2
5 10
6 13
7 3
8 3
9 17
10 14
11 4
12 2
13 1
14 5
15 10
16 13
17 29
18 60
19 51
20 16

About Alok Jaju

Alok Jaju is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 377 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Neuroblastoma Research and Treatments (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Genetics (183 citations), Neurology (92 citations) and Ophthalmology (41 citations). Alok Jaju has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Maura E. Ryan, Steven Don, Charles F. Hildebolt, Geetika Khanna, Timothy G. Keys, Marilyn J. Siegel, Jody D. Ciolino, Kristen W. Yeom, Tord D. Alden and Karen Rychlik. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026